Early detection of colorectal cancer progression by monitoring of free tumour DNA in patient blood and plasma samples

Abstract

Our results indicate a potential for the detection of cell-free tumor DNA as a non-invasive test of metastatic liver disease. Somatic mutations in additional genes (BRAF, PIK3CA) are now being explored as markers to increase the number of patients that can be evaluated from cell-free tumor DNA.